HUE060219T2 - Módszerek az aktivált B-sejtek kappa-könnyû-lánc-erõsítõ nukleáris faktor (NF-KB) diszregulációjának kezelésére az erre rászoruló gazdaszervezetben tojáshéj membrán kompozíciók felhasználásával - Google Patents
Módszerek az aktivált B-sejtek kappa-könnyû-lánc-erõsítõ nukleáris faktor (NF-KB) diszregulációjának kezelésére az erre rászoruló gazdaszervezetben tojáshéj membrán kompozíciók felhasználásávalInfo
- Publication number
- HUE060219T2 HUE060219T2 HUE15905957A HUE15905957A HUE060219T2 HU E060219 T2 HUE060219 T2 HU E060219T2 HU E15905957 A HUE15905957 A HU E15905957A HU E15905957 A HUE15905957 A HU E15905957A HU E060219 T2 HUE060219 T2 HU E060219T2
- Authority
- HU
- Hungary
- Prior art keywords
- dysregulation
- enhancer
- host
- activated
- chain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Meat, Egg Or Seafood Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2015/054742 WO2017062016A1 (en) | 2015-10-08 | 2015-10-08 | METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-ĸB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS |
| EP15905957.5A EP3359170B1 (en) | 2015-10-08 | 2015-10-08 | Methods for treating nuclear factor kappa-light-chain-enhancer of activated b cell (nf-kb) dysregulation in a host in need thereof using eggshell membrane compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE060219T2 true HUE060219T2 (hu) | 2023-02-28 |
Family
ID=58488181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15905957A HUE060219T2 (hu) | 2015-10-08 | 2015-10-08 | Módszerek az aktivált B-sejtek kappa-könnyû-lánc-erõsítõ nukleáris faktor (NF-KB) diszregulációjának kezelésére az erre rászoruló gazdaszervezetben tojáshéj membrán kompozíciók felhasználásával |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10328104B2 (hu) |
| EP (1) | EP3359170B1 (hu) |
| JP (1) | JP2018531212A (hu) |
| KR (1) | KR20180063091A (hu) |
| CN (1) | CN107206029A (hu) |
| AU (1) | AU2015411324B2 (hu) |
| BR (1) | BR112017014304A2 (hu) |
| CA (1) | CA2970101A1 (hu) |
| DK (1) | DK3359170T3 (hu) |
| ES (1) | ES2927890T3 (hu) |
| HU (1) | HUE060219T2 (hu) |
| MX (1) | MX2017007130A (hu) |
| PL (1) | PL3359170T3 (hu) |
| RS (1) | RS63620B1 (hu) |
| RU (1) | RU2713656C2 (hu) |
| WO (1) | WO2017062016A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108991521A (zh) * | 2018-08-10 | 2018-12-14 | 西北农林科技大学 | 一种肠道保护剂及其应用 |
| KR20210052064A (ko) | 2019-10-31 | 2021-05-10 | 강원대학교산학협력단 | 소나무 껍질 추출물을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
| KR102296347B1 (ko) | 2019-11-27 | 2021-09-01 | 강원대학교산학협력단 | 천연물 복합 추출물을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194732A (en) | 1960-10-03 | 1965-07-13 | Neuhauser Irene | Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor |
| US6150090A (en) | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
| US6617171B2 (en) * | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
| US8580315B2 (en) * | 2004-03-10 | 2013-11-12 | Esm Technologies, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
| US8324237B2 (en) * | 2005-05-20 | 2012-12-04 | Smith Charles D | Methods for the treatment and prevention of inflammatory diseases |
| US8211477B2 (en) * | 2007-10-17 | 2012-07-03 | Biova, L.L.C. | Solubilized protein composition obtained from eggshell membrane |
| US20100179103A1 (en) * | 2008-07-21 | 2010-07-15 | Ketan Desai | Curcumin cyclodextrin combination for preventing or treating various diseases |
| JP6056064B2 (ja) * | 2013-11-29 | 2017-01-11 | 国立大学法人 東京大学 | 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物 |
-
2015
- 2015-10-08 CA CA2970101A patent/CA2970101A1/en active Pending
- 2015-10-08 MX MX2017007130A patent/MX2017007130A/es unknown
- 2015-10-08 KR KR1020187008834A patent/KR20180063091A/ko unknown
- 2015-10-08 RS RS20220921A patent/RS63620B1/sr unknown
- 2015-10-08 EP EP15905957.5A patent/EP3359170B1/en active Active
- 2015-10-08 US US15/528,335 patent/US10328104B2/en active Active
- 2015-10-08 JP JP2017529084A patent/JP2018531212A/ja active Pending
- 2015-10-08 CN CN201580076036.0A patent/CN107206029A/zh active Pending
- 2015-10-08 PL PL15905957.5T patent/PL3359170T3/pl unknown
- 2015-10-08 ES ES15905957T patent/ES2927890T3/es active Active
- 2015-10-08 DK DK15905957.5T patent/DK3359170T3/da active
- 2015-10-08 RU RU2017130716A patent/RU2713656C2/ru active
- 2015-10-08 BR BR112017014304A patent/BR112017014304A2/pt not_active Application Discontinuation
- 2015-10-08 HU HUE15905957A patent/HUE060219T2/hu unknown
- 2015-10-08 WO PCT/US2015/054742 patent/WO2017062016A1/en active Application Filing
- 2015-10-08 AU AU2015411324A patent/AU2015411324B2/en active Active
-
2019
- 2019-06-06 US US16/433,683 patent/US11020437B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2713656C2 (ru) | 2020-02-06 |
| US20180339002A1 (en) | 2018-11-29 |
| US20190365824A1 (en) | 2019-12-05 |
| EP3359170A1 (en) | 2018-08-15 |
| JP2018531212A (ja) | 2018-10-25 |
| RU2017130716A (ru) | 2019-02-28 |
| KR20180063091A (ko) | 2018-06-11 |
| DK3359170T3 (da) | 2022-10-10 |
| US11020437B2 (en) | 2021-06-01 |
| AU2015411324B2 (en) | 2023-06-15 |
| BR112017014304A2 (pt) | 2018-03-06 |
| AU2015411324A1 (en) | 2018-03-22 |
| WO2017062016A1 (en) | 2017-04-13 |
| PL3359170T3 (pl) | 2022-11-07 |
| EP3359170B1 (en) | 2022-09-21 |
| CN107206029A (zh) | 2017-09-26 |
| MX2017007130A (es) | 2018-01-30 |
| ES2927890T3 (es) | 2022-11-11 |
| CA2970101A1 (en) | 2017-04-13 |
| RU2017130716A3 (hu) | 2019-05-06 |
| EP3359170A4 (en) | 2019-05-01 |
| RS63620B1 (sr) | 2022-10-31 |
| US10328104B2 (en) | 2019-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1245080A1 (zh) | 自然殺傷細胞的方法和組合物 | |
| ZA201606567B (en) | System and method for activating and deactivating multiple secondary cells | |
| PL3214956T3 (pl) | Roztwór zawierający nikotynę w postaci nieprotonowanej i protonowanej | |
| SG10201608034QA (en) | Fuel tank inerting prefilter assemblies, devices, and methods of use | |
| ZA201504175B (en) | Biocide composition and method for treating water | |
| DK3693158T3 (da) | Asymmetrisk forarbejdningsfremgangsmåde til krumningsreduktion i laminatstrukturer | |
| DK3088353T3 (da) | Bilirubinpartikler og deres fremstilling til anvendelse i terapi | |
| HK1216167A1 (zh) | 具氣孔及纖維的仿真木材及其製法 | |
| SG11201609916RA (en) | Culture method and cell mass | |
| HK1232296A1 (zh) | 種鑒定細胞的方法 | |
| ZA201700021B (en) | Alk kinase inhibitor, and preparation method and use thereof | |
| EP3176267A4 (en) | Method for capturing rare cells in blood | |
| SG11201703487TA (en) | Cell isolation method and cell trapping filter | |
| IL253140B (en) | Asymmetric composite membranes and improved substrates for use in their preparation | |
| EP3237605A4 (en) | Improvements in oligodendroglial cell culturing methods and in methods for treating neurodegenerative disorders by using thyroid hormones or analogues | |
| EP3178010C0 (en) | SYSTEM AND METHOD FOR EXECUTING SYNCHRONIZED FINANCIAL TRANSACTIONS ACROSS MULTIPLE EXCHANGES | |
| GB201418263D0 (en) | Improvements in or relating to burst disc assemblies | |
| EP3008176A4 (en) | COMPOSITIONS AND METHODS FOR REINFORCING THE VIRUS REPLICATION | |
| DK3119901T3 (da) | Fremgangsmåde til behanlding af gærcellevægge med en laminaripentaose-producerende beta-1,3-glucanase | |
| WO2016014319A9 (en) | Animal containment enrichment compositions and methods | |
| GB201417906D0 (en) | Improvements in or realting to brewing | |
| PL3359170T3 (pl) | Sposoby leczenia dysregulacji wzmacniacza łańcucha świetlnego kappa czynnika jądrowego aktywowanych komórek b (nf-kb) u potrzebującego tego gospodarza za pomocą kompozycji błony skorupki jaja | |
| GB201411615D0 (en) | Device and method for cell nuclei preparation | |
| DK3404159T3 (da) | Gitre til brug ved bygningskonstruktion | |
| PL2985394T3 (pl) | Konstrukcja słupowo-ryglowa |